The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Estrogen metabolism and breast cancer
Open accessAbstract
There is currently accumulating evidence that endogenous estrogens play a critical role in the development of breast cancer. Estrogens and their metabolites have been studied in both pre- and postmenopausal women with more consistent results shown in the latter population, in part because of large hormonal variations during the menstrual cycle and far fewer studies having been performed in premenopausal women. In this review we describe in detail estrogen metabolism and associated genetic variations, and provide a critical review of the current literature regarding the role of estrogens and their metabolites in breast cancer risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Williams Textbook of Endocrinology
(2016) · Elsevier eBooks · doi:10.1016/c2013-0-15980-6 · Cited by 3,711
Reactive oxygen species, cellular redox systems, and apoptosis
Circu, M. L., & Aw, T. Y. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.12.022 · Cited by 3,340
Breast Density and Parenchymal Patterns as Markers of Breast Cancer Risk: A Meta-analysis
McCormack, V. A., & dos Santos Silva, I. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0034 · Cited by 2,143
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788 · cited 1×
“Individuals with heterozygous genotype (A/G) show intermediate levels of COMT activity [52,53].”
Manson, J. E., Chlebowski, R. T., Stefanick, M. L., Aragaki, A. K., Rossouw, J. E., Prentice, R. L., Anderson, G., Howard, B. V., Thomson, C. A., LaCroix, A. Z., et al. (2013) · JAMA · doi:10.1001/jama.2013.278040 · Cited by 1,650
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women
Endogenous Hormones Breast Cancer Collaborative Group (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg022 · Cited by 1,093
Reactive Oxygen Species: Players in the Platelet Game
Krötz, F., Sohn, H.-Y., & Pohl, U. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000145574.90840.7d · Cited by 1,006
Functional role of estrogen metabolism in target cells: review and perspectives
Zhu, B. (1998) · Carcinogenesis · doi:10.1093/carcin/19.1.1 · Cited by 971
Simpson, E. R., Clyne, C., Rubin, G., Boon, W. C., Robertson, K., Britt, K., Speed, C., & Jones, M. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081601.142703 · Cited by 773
Validation Studies for Models Projecting the Risk of Invasive and Total Breast Cancer Incidence
Costantino, J. P., Gail, M. H., Pee, D., Anderson, S., Redmond, C. K., Benichou, J., & Wieand, H. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.18.1541 · Cited by 765
Molecular origin of cancer: Catechol estrogen-3,4-quinones as endogenous tumor initiators
Cavalieri, E. L., Stack, D. E., Devanesan, P. D., Todorovic, R., Dwivedy, I., Higginbotham, S., Johansson, S. L., Patil, K. D., Gross, M. L., Gooden, J. K., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10937 · Cited by 727
Williams Textbook of Endocrinology
Reutrakul, S. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/01.mss.0000323673.44568.e8 · Cited by 711
Estrogens as a cause of human cancer: the Richard and Hinda Rosenthal Foundation award lecture.
Henderson, B. E., Ross, R. K., & Bernstein, L. (1988) · PubMed · Cited by 700
Plasma Sex Steroid Hormone Levels and Risk of Breast Cancer in Postmenopausal Women
Hankinson, S. E., Willett, W. C., Manson, J. E., Colditz, G. A., Hunter, D. J., Spiegelman, D., Barbieri, R. L., & Speizer, F. E. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1292 · Cited by 687
Etiology of Hormone Receptor–Defined Breast Cancer: A Systematic Review of the Literature
Althuis, M. D., Fergenbaum, J. H., Garcia-Closas, M., Brinton, L. A., Madigan, M. P., & Sherman, M. E. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1558.13.10 · Cited by 628
A Prospective Study of Endogenous Estrogens and Breast Cancer in Postmenopausal Women
Toniolo, P. G., Levitz, M., Zeleniuch-Jacquotte, A., Banerjee, S., Koenig, K. L., Shore, R. E., Strax, P., & Pasternack, B. S. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.3.190 · Cited by 620
Cytochrome P450-mediated metabolism of estrogens and its regulation in human
Tsuchiya, Y., Nakajima, M., & Yokoi, T. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.10.007 · Cited by 616
Biological Aromatization of Steroids
Ryan, K. J. (1959) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70286-x · Cited by 595
Catechol-O-Methyl Transferase: Pharmacological Aspects and Physiological Role
Guldberg, H. C., & Marsden, C. A. (1975) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06681-5 · Cited by 554
Kaaks, R., Rinaldi, S., Key, T. J., Berrino, F., Peeters, P. H. M., Biessy, C., Dossus, L., Lukanova, A., Bingham, S., Khaw, K.-T., et al. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.01038 · Cited by 527
Missmer, S. A., Eliassen, A. H., Barbieri, R. L., & Hankinson, S. E. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh336 · Cited by 516
Quantitative Assessment of Mammographic Breast Density: Relationship with Breast Cancer Risk
Harvey, J. A., & Bovbjerg, V. E. (2004) · Radiology · doi:10.1148/radiol.2301020870 · Cited by 491
Colditz, G. A. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.950 · Cited by 487
van Landeghem, A. A. J., Poortman, J., Nabuurs, M., & Thijssen, J. H. H. (1985) · PubMed · Cited by 448
Menopause and Breast Cancer Risk 2
(1972) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/48.3.605 · Cited by 421
Kaaks, R., Berrino, F., Key, T., Rinaldi, S., Dossus, L., Biessy, C., Secreto, G., Amiano, P., Bingham, S., Boeing, H., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji132 · Cited by 420
4-Hydroxylation of estrogens as marker of human mammary tumors.
Liehr, J. G., & Ricci, M. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.8.3294 · Cited by 414
Cauley, J. A., Lucas, F. L., Kuller, L. H., Stone, K., Browner, W., Cummings, S. R., & for the Study of Osteoporotic Fractures Research Group (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-4_part_1-199902160-00004 · Cited by 409
(2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70301-2 · Cited by 399
Endogenous Hormones and Breast Cancer Collaborative Group (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.254 · Cited by 391
Endogenous Steroid Hormone Concentrations and Risk of Breast Cancer Among Premenopausal Women
Eliassen, A. H., Missmer, S. A., Tworoger, S. S., Spiegelman, D., Barbieri, R. L., Dowsett, M., & Hankinson, S. E. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj376 · Cited by 385
Serum Sex Hormone Levels After Menopause and Subsequent Breast Cancer
Berrino, F., Muti, P., Micheli, A., Bolelli, G., Krogh, V., Sciajno, R., Pisani, P., Panico, S., & Secreto, G. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.5.291 · Cited by 335
Breast cancer: hormones and other risk factors
Hulka, B. S., & Moorman, P. G. (2001) · Maturitas · doi:10.1016/s0378-5122(00)00196-1 · Cited by 314
Lavigne, J. A., Helzlsouer, K. J., Huang, H. Y., Strickland, P. T., Bell, D. A., Selmin, O., Watson, M. A., Hoffman, S. C., Comstock, G. W., & Yager, J. D. (1997) · PubMed · Cited by 311
Chapter 6: Estrogen Metabolism by Conjugation
Raftogianis, R., Creveling, C., Weinshilboum, R., & Weisz, J. (2000) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a024234 · Cited by 297
Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1→q11.2
Grossman, M. H., Emanuel, B. S., & Budarf, M. L. (1992) · Genomics · doi:10.1016/0888-7543(92)90316-k · Cited by 296
Free radical generation by redox cycling of estrogens
Liehr, J. G., & Roy, D. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90108-u · Cited by 295
Thomas, H., Key, T., Allen, D., Moore, J., Dowsett, M., Fentiman, I., & Wang, D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.398 · Cited by 289
2‐Methoxyestradiol, a Promising Anticancer Agent
Lakhani, N. J., Sarkar, M. A., Venitz, J., & Figg, W. D. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.2.165.32088 · Cited by 274
Muti, P., Bradlow, H. L., Micheli, A., Krogh, V., Freudenheim, J. L., Schünemann, H. J., Stanulla, M., Yang, J., Sepkovic, D. W., Trevisan, M., et al. (2000) · Epidemiology · doi:10.1097/00001648-200011000-00004 · Cited by 266
Roodi, N., Bailey, L. R., Kao, W.-Y., Verrier, C. S., Yee, C. J., Dupont, W. D., & Parl, F. F. (1995) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/87.6.446 · Cited by 266
Telang, N. T., Suto, A., Wong, G. Y., Osborne, M. P., & Bradlow, H. L. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.8.634 · Cited by 261
Dawling, S., Roodi, N., Mernaugh, R. L., Wang, X., & Parl, F. F. (2001) · PubMed · Cited by 250
A polymorphism in the CYP17 gene increases the risk of breast cancer.
Feigelson, H. S., Coetzee, G. A., Kolonel, L. N., Ross, R. K., & Henderson, B. E. (1997) · PubMed · Cited by 247
Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells.
Schneider, J., Huh, M. M., Bradlow, H. L., & Fishman, J. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42922-x · Cited by 246
Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility
de Jong, M. M., Nolte, I. M., te Meerman, G. J., van der Graaf, W. T. A., Oosterwijk, J. C., Kleibeuker, J. H., Schaapveld, M., & de Vries, E. G. E. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.4.225 · Cited by 235
Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
Dorgan, J. F., Longcope, C., Stephenson, H. E., Falk, R. T., Miller, R., Franz, C., Kahle, L., Campbell, W. S., Tangrea, J. A., & Schatzkin, A. G. (1996) · PubMed · Cited by 219
Urinary estrogen metabolites and breast cancer: a case-control study.
Kabat, G. C., Chang, C., Sparano, J. A., Sepkovie, D. W., Hu, X. P., Khalil, A. I., Rosenblatt, R., & Bradlow, H. L. (1997) · PubMed · Cited by 211
Estrogen Metabolism and Risk of Breast Cancer in Postmenopausal Women
Fuhrman, B. J., Schairer, C., Gail, M. H., Boyd-Morin, J., Xu, X., Sue, L. Y., Buys, S. S., Isaacs, C., Keefer, L. K., Veenstra, T. D., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djr531 · Cited by 205
Bradlow, H. L., Hershcopf, R. J., Martucci, C. P., & Fishman, J. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.18.6295 · Cited by 204
Steroid sulfotransferases and steroid sulfate sulfatases: characteristics and biological roles
Hobkirk, R. (1985) · Canadian Journal of Biochemistry and Cell Biology · doi:10.1139/o85-141 · Cited by 201
Molecular Characteristics of Catechol Estrogen Quinones in Reactions with Deoxyribonucleosides
Stack, D. E., Byun, J., Gross, M. L., Rogan, E. G., & Cavalieri, E. L. (1996) · Chemical Research in Toxicology · doi:10.1021/tx960002q · Cited by 201
Genetic polymorphisms in catechol-O-methyltransferase, menopausal status, and breast cancer risk.
Thompson, P. A., Shields, P. G., Freudenheim, J. L., Stone, A., Vena, J. E., Marshall, J. R., Graham, S., Laughlin, R., Nemoto, T., Kadlubar, F. F., et al. (1998) · PubMed · Cited by 200
Postmenopausal plasma sex hormone levels and breast cancer risk over 20 years of follow-up
Zhang, X., Tworoger, S. S., Eliassen, A. H., & Hankinson, S. E. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2391-z · Cited by 189
2-Hydroxyestrone: the 'good' estrogen
Bradlow, H. L., Telang, N., Sepkovic, D. W., & Osborne, M. P. (1996) · Journal of Endocrinology · doi:10.1677/joe.0.150s259 · Cited by 188
Expression of cytochromes P450 in human breast tissue and tumors.
Huang, Z., Fasco, M. J., Figge, H. L., Keyomarsi, K., & Kaminsky, L. S. (1996) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)07451-3 · Cited by 184
Miller, W. L., & Strauss, J. F. (1999) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00153-8 · Cited by 184
Cushman, M., He, H.-M., Katzenellenbogen, J. A., Lin, C. M., & Hamel, E. (1995) · Journal of Medicinal Chemistry · doi:10.1021/jm00012a003 · Cited by 183
Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
Watanabe, J., Shimada, T., Gillam, E. M. J., Ikuta, T., Suemasu, K., Higashi, Y., Gotoh, O., & Kawajiri, K. (2000) · Pharmacogenetics · doi:10.1097/00008571-200002000-00004 · Cited by 176
A prospective study of endogenous hormones and breast cancer.
Kj, H., Aj, A., Tl, B., Longcope, C., Gb, G., & Comstock, G. W. (1994) · PubMed · Cited by 170
Changing Concepts: Menopausal Hormone Therapy and Breast Cancer
Chlebowski, R. T., & Anderson, G. L. (2012) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djs014 · Cited by 169
Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up
Meilahn, E., De Stavola, B., Allen, D., Fentiman, I., Bradlow, H., Sepkovic, D., & Kuller, L. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.663 · Cited by 168
SEX HORMONE LEVELS IN SERUM IN RELATION TO THE DEVELOPMENT OF BREAST CANCER
WYSOWSKI, D. K., COMSTOCK, G. W., HELSING, K. J., & LAU, H. L. (1987) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114596 · Cited by 163
Unbalanced metabolism of endogenous estrogens in the etiology and prevention of human cancer
Cavalieri, E. L., & Rogan, E. G. (2011) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2011.03.008 · Cited by 162
A prospective study of estradiol and breast cancer in Japanese women.
Kabuto, M., Akiba, S., Stevens, R. G., Neriishi, K., & Land, C. E. (2000) · PubMed · Cited by 156
Genetic polymorphism of cytochrome P450-1B1 and risk of breast cancer.
Zheng, W., Xie, D., Jin, F., Cheng, J., Dai, Q., Wen, W., Shu, X., & Gao, Y. (2000) · PubMed · Cited by 151
Osborne, M. P., Bradlow, H. L., Wong, G. Y., & TELANG, N. T. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.23.1917 · Cited by 149
Endogenous estrogen, testosterone and progesterone levels in relation to breast cancer risk
Hankinson, S. E., & Eliassen, A. H. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2007.05.012 · Cited by 149
Effects of 17 beta-estradiol metabolites on cell cycle events in MCF-7 cells.
Lottering, M.-L., Haag, M., & Seegers, J. C. (1992) · PubMed · Cited by 142
The molecular etiology of breast cancer: Evidence from biomarkers of risk
Gaikwad, N. W., Yang, L., Muti, P. C., Meza, J. L., Pruthi, S., Ingle, J. N., Rogan, E. G., & Cavalieri, E. L. (2007) · International Journal of Cancer · doi:10.1002/ijc.23329 · Cited by 137
Urinary 2-Hydroxyestrone/16 -Hydroxyestrone Ratio and Risk of Breast Cancer in Postmenopausal Women
Ursin, G., London, S. J., Stanczyk, F. Z., Gentzschein, E., Paganini‐Hill, A., Ross, R. K., & Pike, M. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.12.1067 · Cited by 137
Endogenous Sex Hormone Levels and Mammographic Density among Postmenopausal Women
Tamimi, R. M., Hankinson, S. E., Colditz, G. A., & Byrne, C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0558 · Cited by 133
Kerlan, V., Dréano, Y., Bercovici, J. P., Beaune, P. H., Floch, H. H., & Berthou, F. (1992) · Biochemical Pharmacology · doi:10.1016/0006-2952(92)90068-t · Cited by 129
Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden)
Manjer, J., Johansson, R., Berglund, G. L., Janzon, L., Kaaks, R., Ågren, Å., & Lenner, P. (2003) · Cancer Causes & Control · doi:10.1023/a:1025671317220 · Cited by 125
The role of lipoproteins in the regulation of progesterone secretion by the human corpus luteum
Carr, B. R., MacDonald, P. C., & Simpson, E. R. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46511-8 · Cited by 122
Falk, R. T., Brinton, L. A., Dorgan, J. F., Fuhrman, B. J., Veenstra, T. D., Xu, X., & Gierach, G. L. (2013) · Breast Cancer Research · doi:10.1186/bcr3416 · Cited by 121
Zeleniuch‐Jacquotte, A., Bruning, P. F., Bonfrèr, J. M. G., Koenig, K. L., Shore, R. E., Kirn, M., Pasternack, B. S., & Toniolo, P. G. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009059 · Cited by 119
Role of polymorphic human cytochrome P450 enzymes in estrone oxidation
Cribb, A. E., Knight, M. J., Dryer, D., Guernsey, J., Hender, K., Tesch, M., & Saleh, T. M. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0801 · Cited by 118 · cited 1×
“These enzymes, along with CYP1A2, catalyze the C2 hydroxylation of parent estrogens to their respective catechol estrogens [22].”
Risk Factor Modification and Projections of Absolute Breast Cancer Risk
Petracci, E., Decarli, A., Schairer, C., Pfeiffer, R. M., Pee, D., Masala, G., Palli, D., & Gail, M. H. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr172 · Cited by 116
Lavigne, J. A., Goodman, J. E., Fonong, T., Odwin, S.-A., He, P., Roberts, D. W., & Yager, J. D. (2001) · PubMed · Cited by 113
Greendale, G. A., Palla, S. L., Ursin, G., Laughlin, G. A., Crandall, C. J., Pike, M. C., & Reboussin, B. A. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi286 · Cited by 111
Circulating Steroid Hormone Levels and Risk of Breast Cancer for Postmenopausal Women
Baglietto, L., Severi, G., English, D. R., Krishnan, K., Hopper, J. L., McLean, C., Morris, H. A., Tilley, W. D., & Giles, G. G. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0532 · Cited by 109
Thomas, H., Key, T., Allen, D., Jw, M., Dowsett, M., Fentiman, I., & Wang, D. Y. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.183 · Cited by 108
Sex Hormones and Postmenopausal Breast Cancer: A Prospective Study in an Adult Community
Garland, C. F., Friedlander, N. J., Barrett-Connor, E. L., & Khaw, K. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116228 · Cited by 107
Gordon, G., Bush, T. L., Helzlsouer, K. J., Miller, S. R., & Comstock, G. W. (1990) · PubMed · Cited by 106
Role of Estradiol Metabolism and CYP1A1 Polymorphisms in Breast Cancer Risk
Taioli, E., Bradlow, H. L., Garbers, S., Sepkovic, D. W., Osborne, M. P., Trachman, J. D., Ganguly, S., & GARTE, S. J. (1999) · Cancer Detection and Prevention · doi:10.1046/j.1525-1500.1999.09912.x · Cited by 104
Lønning, P. E., Helle, H., Duong, N. K., Ekse, D., Aas, T., & Geisler, J. (2009) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2009.06.005 · Cited by 100
Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers
van Aswegen, C. H., Purdy, R. H., & Wittliff, J. L. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90380-4 · Cited by 100
Eliassen, A. H., Spiegelman, D. L., Xu, X., Keefer, L. K., Veenstra, T. D., Barbieri, R. L., Willett, W. C., Hankinson, S. E., & Ziegler, R. G. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2507 · Cited by 98
Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer
Yim, D., Park, S. K., Yoo, K.-Y., Yoon, K., Chung, H. H., Kang, H. J., Ahn, S.-H., Noh, D., Choe, K., Jang, I., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200106000-00001 · Cited by 97
Dorgan, J. F., Stanczyk, F. Z., Longcope, C., et al. (1997) · PubMed · Cited by 95
Genotoxicity of steroidal estrogens
Russo, J., & Russo, I. H. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.05.007 · Cited by 92
Gupta, M. S., McDougal, A. J., & Safe, S. H. (1998) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(98)00135-6 · Cited by 92
Endogenous oestrogens and breast cancer risk in premenopausal and postmenopausal women
Key, T. J. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.029 · Cited by 89
Diet and Breast Cancer: Understanding Risks and Benefits
Thomson, C. A. (2012) · Nutrition in Clinical Practice · doi:10.1177/0884533612454302 · Cited by 88
Rosenberg, C. R., Pasternack, B. S., Shore, R. E., Koenig, K. L., & Toniolo, P. G. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117278 · Cited by 86
Beattie, M. S., Costantino, J. P., Cummings, S. R., Wickerham, D. L., Vogel, V. G., Dowsett, M., Folkerd, E. J., Willett, W. C., Wolmark, N., & Hankinson, S. E. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj011 · Cited by 86
Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
Mitrunen, K., Jourenkova, N., Kataja, V. V., Eskelinen, M. J., Kosma, V., Benhamou, S., Kang, D., Vainio, H., Uusitupa, M. I. J., & Hirvonen, A. (2001) · PubMed · Cited by 86
Dorgan, J. F., Stanczyk, F. Z., Kahle, L., & Brinton, L. A. (2010) · Breast Cancer Research · doi:10.1186/bcr2779 · Cited by 85
Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk
Rylander‐Rudqvist, T. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg114 · Cited by 84
Fowke, J. H., Dai, Q., Bradlow, H. L., Shu, X., Gao, Y.-T., Cheng, J.-R., Jin, F., & Zheng, W. (2002) · Steroids · doi:10.1016/s0039-128x(02)00116-2 · Cited by 83
Fortner, R. T., Eliassen, A. H., Spiegelman, D. L., Willett, W. C., Barbieri, R. L., & Hankinson, S. E. (2013) · Breast Cancer Research · doi:10.1186/bcr3394 · Cited by 82
Eliassen, A. H., Missmer, S. A., Tworoger, S. S., & Hankinson, S. E. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7432 · Cited by 81
Vandewalle, B., & Lefèbvre, J. L. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90135-4 · Cited by 79
Methoxyestrogens exert feedback inhibition on cytochrome P450 1A1 and 1B1.
Dawling, S., Roodi, N., & Parl, F. F. (2003) · PubMed · Cited by 78
Wen, W., Cai, Q., Shu, X., Cheng, J., Parl, F. F., Pierce, L. A., Gao, Y., & Zheng, W. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0392 · Cited by 78
Dallal, C. M., Tice, J. A., Buist, D. S. M., Bauer, D. C., Lacey, J. V., Cauley, J. A., Hue, T. F., LaCroix, A. Z., Falk, R. T., Pfeiffer, R. M., et al. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt367 · Cited by 74
Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells
Lu, F., Zahid, M., SAEED, M. K., Cavalieri, E. L., & Rogan, E. G. (2007) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2006.12.102 · Cited by 73
Oestradiol 16 alpha-hydroxylase: a risk marker for breast cancer.
Bradlow, H. L., Re, H., & Jf, F. (1986) · PubMed · Cited by 71
Assessing breast cancer risk in women.
Steiner, E. A., Klubert, D., & Knutson, D. (2008) · PubMed · Cited by 70
Breast Cancer Risk Associated with CYP1A1 Genetic Polymorphisms in Japanese Women
Miyoshi, Y., Takahashi, Y., Egawa, C., & Noguchi, S. (2002) · The Breast Journal · doi:10.1046/j.1524-4741.2002.08404.x · Cited by 67
Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation
Lønning, P. E., Haynes, B. P., Straume, A. H., Dunbier, A. K., Helle, H., Knappskog, S., & Dowsett, M. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0043 · Cited by 67
Estrogen Metabolites and the Risk of Breast Cancer in Older Women
Cauley, J. A., Zmuda, J. M., Danielson, M. E., Ljung, B., Bauer, D. C., Cummings, S. R., & Kuller, L. H. (2003) · Epidemiology · doi:10.1097/01.ede.0000091607.77374.74 · Cited by 63
Effects of sex steroids on proliferation in normal mammary tissue
Söderqvist, G. (1998) · Annals of Medicine · doi:10.3109/07853899809002598 · Cited by 63
Eliassen, A. H., Missmer, S. A., Tworoger, S. S., & Hankinson, S. E. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0262 · Cited by 63
Chattopadhyay, S., Siddiqui, S., Akhtar, S., Najm, M. Z., Deo, S. V. S., Shukla, N. K., & Husain, S. A. (2014) · Tumor Biology · doi:10.1007/s13277-013-1594-1 · Cited by 59
Dehydroepiandrosterone sulfate and breast cancer risk.
Barrett-Connor, E. L., Friedlander, N. J., & Khaw, K. (1990) · PubMed · Cited by 57
Potentially functional polymorphisms in ESR1 and breast cancer risk: a meta-analysis
Li, N., Dong, J., Hu, Z., Shen, H., & Dai, M. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0532-9 · Cited by 56
Setiawan, V. W., Schumacher, F. R., Haiman, C. A., Stram, D. O., Albanes, D., Altshuler, D., Berglund, G. L., Buring, J. E., Calle, E. E., Clavel‐Chapelon, F., et al. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0589 · Cited by 56
Yu, K., Rao, N.-Y., Chen, A.-X., Fan, L., Yang, C., & Shao, Z. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0891-2 · Cited by 55
Estradiol metabolism: an endocrine biomarker for modulation of human mammary carcinogenesis.
TELANG, N. T., Katdare, M., Bradlow, H. L., et al. (1997) · Environmental Health Perspectives · doi:10.1289/ehp.97105s3559 · Cited by 54
Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis
Walker, K., Bratton, D. J., & Frost, C. D. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.358 · Cited by 48
Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis
Qin, X. Y., Peng, Q., Qin, A., Chen, Z., Lin, L., Deng, Y., Xie, L., Xu, J., Li, H., Li, T., et al. (2012) · Diagnostic Pathology · doi:10.1186/1746-1596-7-136 · Cited by 48
Genetic Polymorphisms in the Catechol Estrogen Metabolism Pathway and Breast Cancer Risk
Reding, K. W., Weiss, N. S., Chen, C., Li, C. I., Carlson, C. S., Wilkerson, H.-W., Farin, F. M., Thummel, K. E., Daling, J. R., & Malone, K. E. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0917 · Cited by 47
Verheus, M., Peeters, P. H. M., van Noord, P. A. H., van der Schouw, Y. T., Grobbee, D. E., & van Gils, C. H. (2007) · Breast Cancer Research · doi:10.1186/bcr1758 · Cited by 46
Urinary Hydroxyestrogens and Breast Cancer Risk among Postmenopausal Women: A Prospective Study
Wellejus, A., Olsen, A., Tjønneland, A. M., Thomsen, B. L., Overvad, K., & Loft, S. H. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0934 · Cited by 46
Circulating Estrogen Metabolites and Risk of Breast Cancer in Postmenopausal Women
Arslan, A. A., Koenig, K. L., Lenner, P., Afanasyeva, Y., Shore, R. E., Chen, Y., Lundin, E., Toniolo, P. G., Hallmans, G., & Zeleniuch‐Jacquotte, A. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0009 · Cited by 45
Circulating Sex Steroids and Breast Cancer Risk in Premenopausal Women
Hankinson, S. E., & Eliassen, A. H. (2010) · Hormones and Cancer · doi:10.1007/s12672-009-0003-0 · Cited by 44
Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort
Schernhammer, E. S., Sperati, F., Razavi, P., Agnoli, C., Sieri, S., Berrino, F., Krogh, V., Abbagnato, C. A., Grioni, S., Blandino, G., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3438 · Cited by 42
Gordon, G., Bush, T., Helzlsouer, K. J., Miller, S., & Comstock, G. (1991) · Maturitas · doi:10.1016/0378-5122(91)90313-f · Cited by 42
Estrogen-related genes and their contribution to racial differences in breast cancer risk
Reding, K. W., Chen, C., Lowe, K. A., Doody, D. R., Carlson, C. S., Chen, C. T., Houck, J., Weiss, L. K., Marchbanks, P. A., Bernstein, L., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9925-x · Cited by 37
Mammographic density - a useful biomarker for breast cancer risk in epidemiologic studies
Ursin, G., & Qureshi, S. A. (2009) · Norsk Epidemiologi · doi:10.5324/nje.v19i1.13 · Cited by 36
Persistent estrogen responsiveness of ras oncogene-transformed mouse mammary epithelial cells
Suto, A., Bradlow, H. L., Wong, G. Y., Osborne, M. P., & TELANG, N. T. (1992) · Steroids · doi:10.1016/0039-128x(92)90058-h · Cited by 36
Postmenopausal Hormone Use, Screening, and Breast Cancer: Characterization and Control of a Bias
Joffe, M. M., Byrne, C., & Colditz, G. A. (2001) · Epidemiology · doi:10.1097/00001648-200107000-00013 · Cited by 35
Circulating Estrogen Metabolites and Risk for Breast Cancer in Premenopausal Women
Arslan, A. A., Shore, R. E., Afanasyeva, Y., Koenig, K. L., Toniolo, P. G., & Zeleniuch‐Jacquotte, A. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0312 · Cited by 33
Obi, N., Vrieling, Heinz, & Chang-Claude (2011) · International Journal of Women s Health · doi:10.2147/ijwh.s7595 · Cited by 32
Chen, Y., Gammon, M. D., Teitelbaum, S. L., Britton, J. A., Terry, M. B., Shantakumar, S., Eng, S. M., Wang, Q., Gurvich, I., Neugut, A. I., et al. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn042 · Cited by 31
Pharmacogenetics of Estrogen Metabolism and Transport in Relation to Cancer
Lakhani, N. J., Venitz, J., Figg, W. D., & Sparreboom, A. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489244 · Cited by 29
A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk
Talbott, K. E., Gammon, M. D., Kibriya, M. G., Chen, Y., Teitelbaum, S. L., Long, C., Gurvich, I., Santella, R. M., & Ahsan, H. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9794-2 · Cited by 29
Cited by
Estrogen receptor signaling mechanisms
(2019) · Advances in Protein Chemistry and Structural Biology · doi:10.1016/bs.apcsb.2019.01.001 · Cited by 988
Goedert, J. J., Jones, G., Hua, X., Xu, X., Yu, G., Flores, R., Falk, R. T., Gail, M. H., Shi, J., Ravel, J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv147 · Cited by 393
Ervin, S. M., Li, H., Lim, L., Roberts, L. R., Liang, X., Mani, S., & Redinbo, M. R. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010950 · Cited by 397
Redox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 359
Morsi, R., Bilal, M., Iqbal, H. M. N., & Ashraf, S. S. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.136572 · Cited by 317
Metadata
- Authors
- Samavat, H., & Kurzer, M. S.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2015-01
- Volume
- 356
- Issue
- 2
- Pages
- 231-243
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W2045042834
- Cited by
- 380
- References
- 141
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.